Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Gilead Sciences Inc (NASDAQ:GILD)

81.74
BATS BZX Real-Time Price
As of 1:50pm ET
 +0.69 / +0.85%
Today’s Change
77.92
Today|||52-Week Range
120.37
-19.22%
Year-to-Date
Express Scripts (ESRX) Posts In-Line Earnings, Lags Revenues (Revised)
11:56am / Zacks.com - Paid Partner Content
Post-Market Activity Shows Gilead (GILD) Down
Jul 25 / TheStreet.com - Paid Partner Content
Watch for Drug Stocks Earnings on Jul 28: BMY, CELG & More
10:28am / Zacks.com - Paid Partner Content
Biotech Earnings Battle: Gilead (GILD) vs. Amgen (AMGN)
Jul 25 / Zacks.com - Paid Partner Content
The Drug-Price War Just Took a Big New Twist
10:24am / MotleyFool.com - Paid Partner Content
Gilead Lowers Product Sales Guidance on Weak Hepatitis C Sales
Jul 25 / TheStreet.com - Paid Partner Content
Buy Gilead Sciences While It's Wallowing
7:36am / TheStreet.com - Paid Partner Content
Expect an Interesting Week Ahead
Jul 25 / TheStreet.com - Paid Partner Content
Buy Gilead Sciences While It's Wallowing
7:21am / TheStreet.com - Paid Partner Content
These 5 Healthcare Stocks Are Ridiculously Cheap
Jul 25 / MotleyFool.com - Paid Partner Content
After GILD Earnings, Which Biomed Stock is Best Right Now?
Jul 26 / Zacks.com - Paid Partner Content
Where Is the Insider Buying?
Jul 25 / TheStreet.com - Paid Partner Content
Harvoni Sales Declines Hurt Gilead Sciences Inc. in Q2
Jul 26 / MotleyFool.com - Paid Partner Content
Market's Lower, But These 3 Stocks Aren't
Jul 25 / TheStreet.com - Paid Partner Content
Gilead Sciences (GILD) Stock Plunges on Q2 Results, RBC Cuts Price Target
Jul 26 / TheStreet.com - Paid Partner Content
Is Timeframe on Your Side?
Jul 25 / TheStreet.com - Paid Partner Content
3 Stocks Dragging The Health Care Sector Downward
Jul 26 / TheStreet.com - Paid Partner Content
Is Time Frame on Your Side?
Jul 25 / TheStreet.com - Paid Partner Content
3 Key Takeaways Following Gilead Sciences' Second-Quarter Conference Call
Jul 26 / MotleyFool.com - Paid Partner Content
I'm Bullish on Biotechs
Jul 25 / TheStreet.com - Paid Partner Content
Jerome Dodson Comments on Gilead
Jul 26 / GuruFocus News - Paid Partner Content
Busiest Week for Q2 Earnings Now Underway
Jul 25 / Zacks.com - Paid Partner Content
Jerome Dodson's Parnassus Fund 2nd Quarter Commentary
Jul 26 / GuruFocus News - Paid Partner Content
Morning Movers: YHOO, VZ, DHR, GILD
Jul 25 / TheStreet.com - Paid Partner Content
Rev's Forum: A Hard Market to Embrace
Jul 26 / TheStreet.com - Paid Partner Content
Stocks: 5 things to know before the open
Jul 25 / CNNMoney.com
Why Gilead Can't Easily Copy Celgene's 'Partner Partner Partner' Deal-Making Playbook
Jul 26 / TheStreet.com - Paid Partner Content
5 Reasons Biotech Stocks Are Smart Investments
Jul 24 / MotleyFool.com - Paid Partner Content
Gilead (GILD) Beats on Q2 Earnings, Cuts 2016 Sales View
Jul 26 / Zacks.com - Paid Partner Content
3 Stocks That Turned $10,000 Into $1 Million
Jul 24 / MotleyFool.com - Paid Partner Content
The Zacks Analyst Blog Highlights: Texas Instruments, Gilead Sciences and Las Vegas S...
Jul 26 / Zacks.com - Paid Partner Content
I Just Bought These 4 Fast-Growing Biotech Stocks
Jul 23 / MotleyFool.com - Paid Partner Content
Express Scripts (ESRX) Tops Q2 Earnings, Lags Revenues
Jul 26 / Zacks.com - Paid Partner Content
These 4 Stocks Could See Negative Catalysts From Earnings -- but What Do the Charts S...
Jul 22 / TheStreet.com - Paid Partner Content
Beware of False Profits
Jul 26 / TheStreet.com - Paid Partner Content
Gilead Sciences (GILD) Stock Drops Ahead of Q2 Earnings Report
Jul 22 / TheStreet.com - Paid Partner Content
Stock Futures Mixed as Fed Meets, Verizon and McDonald's Tumble
Jul 26 / TheStreet.com - Paid Partner Content
Medical Stocks Reporting Early Next Week: GILD, LLY & More
Jul 22 / Zacks.com - Paid Partner Content
Wait for Another 10% Drop In Gilead Before Buying
Jul 26 / TheStreet.com - Paid Partner Content
Can GoPro (GPRO) Spring a Surprise this Earnings Season?
Jul 22 / Zacks.com - Paid Partner Content
Stocks: 5 things to know before the open
Jul 26 / CNNMoney.com
Gilead (GILD) Stock Likely to Beat This Earnings Season
Jul 21 / Zacks.com - Paid Partner Content
7 Key Figures From Gilead Sciences' Q2 Earnings
Jul 25 / MotleyFool.com - Paid Partner Content
What's in Store for TransUnion (TRU) This Earnings Season?
Jul 21 / Zacks.com - Paid Partner Content
Roche (RHHBY) Misses on Q2 Revenues, New Launches in Focus
Jul 25 / Zacks.com - Paid Partner Content
3 Healthcare ETFs to Buy as JNJ Beats Q2 Earnings
Jul 21 / Zacks.com - Paid Partner Content
Q2 Earnings After the Bell Monday: TXN, GILD, LVS
Jul 25 / Zacks.com - Paid Partner Content
4 Small-Cap Biotechs With Big Stories to Tell
Jul 21 / TheStreet.com - Paid Partner Content
Gilead (GILD) Stock Falls on Sales Miss and Lower 2016 Revenues Guidance
Jul 25 / Zacks.com - Paid Partner Content
3 Enormously Important Things You Won't See in Gilead Sciences' Q2 Results
Jul 21 / MotleyFool.com - Paid Partner Content